Source: Annual Congress 2001 - Imaging of the thorax: from conventional radiography to CT, MR and PET
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sano, T. Shioya, K. Takahashi, J. Hatazawa, M. Kagaya, M. Sasaki, M. Miura (Akita, Japan). Visualization and quantification of muscarinic receptors by positron emission tomography (PET) in human lung in vivo. Eur Respir J 2001; 16: Suppl. 31, 1575

Member's Comments

No comment yet.

Related content which might interest you: Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer Year: 2008 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009 Assessing nodules detected in lung cancer screening: the value of positron emission tomography Source: Eur Respir J 2015; 45: 314-316 Year: 2015 Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013 Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 The place of non-invasive techniques (CT - PET - CT) Source: Annual Congress 2007 - Mediastinal staging for NSCLC Year: 2007 Advances in chest imagery Source: Annual Congress 2006 - Clinical year in review Year: 2006 Quantitative 18F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD Source: ERJ Open Res, 7 (3) 00699-2020; 10.1183/23120541.00699-2020 Year: 2021 Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Single photon emission computed tomography (SPECT) in the non-invasive diagnosis cardiac sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 356s Year: 2006 The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245 Year: 2004 Influence of acute smoking on pulmonary inflammatory cell activity measured by positron emission tomography (PET) in asymptomatic cigarette smokers Source: Annual Congress 2005 - New modalities and application in lung and airway imaging Year: 2005 Measurement of airway inflammation in smokers by means of positron emission tomography Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation Year: 2012 Imaging can replace mediastinoscopy: PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Downregulation of the peripheral benzodiazepine receptor in macrophages (Mφ) measured by positron emission tomography (PET) in fibrosing alveolitis due to systemic sclerosis Source: Eur Respir J 2003; 22: Suppl. 45, 532s Year: 2003 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013